Groundbreaking research by Markiewski et al. demonstrated that complement activation plays a crucial role in shaping the TME by inhibiting T cell functions, evidenced by the fact that C3 deficiency or C5aR inhibition impaired tumor growth and enhanced the infiltration of CD8+ T cells into the TME. The gene discussed is C5AR1; the disease is neoplasm.